Our experiments also demonstrated that UTMD treatment promoted autophagy in pancreatic cancer cells, evidenced by the formation of autophagosomes, a significant increase in LC3B-II/I and Beclin1 expression, and a decrease in P62 expression. This evidence concerns the gene BECN1 and pancreatic neoplasm.